|
Index of reports
> Cases with Sepsis (91)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Carboplatin where reactions include sepsis. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 91 Next >>
Possible Carboplatin side effects in 58 year old male
Reported by a consumer/non-health professional from Argentina on 2012-08-24
Patient: 58 year old male
Reactions: Hepatotoxicity, Neoplasm Malignant, Sepsis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Yervoy
Dosage: no of inf:2 infusion on 9feb12
Indication: Metastatic Malignant Melanoma
Start date: 2012-02-09
Carboplatin
Start date: 2012-01-01
Possible Carboplatin side effects in 58 year old female
Reported by a physician from United States on 2012-08-13
Patient: 58 year old female, weighing 79.0 kg (173.8 pounds)
Reactions: Obstruction Gastric, Vomiting, Hyperkalaemia, Nausea, Supraventricular Tachycardia, Febrile Neutropenia, Aspiration, Sepsis, Abdominal Distension, Cardiac Arrest
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ixabepilone
Dosage: last dose administerd:12/may/2011
Indication: Endometrial Cancer
Start date: 2012-05-12
Avastin
Dosage: last dose administered on 12/may/2011
Indication: Endometrial Cancer
Start date: 2012-05-12
Carboplatin
Dosage: auc=6; last dose administered on:12/may/2011
Indication: Endometrial Cancer
Start date: 2011-05-12
Other drugs received by patient: Protonix; Norco; Compazine; Synthroid; Ventolin; Lovenox
Possible Carboplatin side effects in 58 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient: 58 year old female, weighing 79.0 kg (173.8 pounds)
Reactions: Obstruction Gastric, Vomiting, Hyperkalaemia, Nausea, Supraventricular Tachycardia, Febrile Neutropenia, Aspiration, Sepsis, Abdominal Distension, Cardiac Arrest
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ixabepilone
Dosage: last administered 12may2011
Indication: Endometrial Cancer
Start date: 2011-05-12
Bevacizumab
Dosage: last administered 12may2011
Indication: Endometrial Cancer
Start date: 2011-05-12
Carboplatin
Dosage: last administered 12may2011
Indication: Endometrial Cancer
Start date: 2011-05-12
Other drugs received by patient: Norco; Compazine; Synthroid; Ventolin; Protonix; Lovenox
Possible Carboplatin side effects in 65 year old female
Reported by a physician from Germany on 2012-07-23
Patient: 65 year old female, weighing 46.4 kg (102.1 pounds)
Reactions: Weight Decreased, Fistula, Nausea, Anaemia, General Physical Health Deterioration, Fatigue, Sepsis, Decreased Appetite, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Avastin
Indication: Ovarian Cancer
Start date: 2012-03-21
End date: 2012-04-18
Carboplatin
Dosage: auc 5,
Indication: Ovarian Cancer
Start date: 2012-02-27
End date: 2012-04-18
Paclitaxel
Dosage: last dose:15/may/2012
Indication: Ovarian Cancer
Start date: 2012-02-27
End date: 2012-04-18
Avastin
Dosage: last dose:15/may/2012
End date: 2012-06-10
Carboplatin
Dosage: auc 5, last dose:15/may/2012
End date: 2012-06-10
Paclitaxel
Dosage: last dose:15/may/2012
End date: 2012-06-10
Other drugs received by patient: Novalgin; Pantoprazole; Zolpidem
Possible Carboplatin side effects in 76 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-17
Patient: 76 year old male, weighing 70.0 kg (154.0 pounds)
Reactions: Hypotension, Disseminated Intravascular Coagulation, Headache, Malaise, Sepsis, Neutropenia, Cardiac Arrest, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Carboplatin
Dosage: dose unit: unknown
Indication: Small Cell Lung Cancer Stage Unspecified
Start date: 2010-10-04
End date: 2010-10-04
Etoposide
Dosage: dose unit: unknown
Indication: Small Cell Lung Cancer Stage Unspecified
Start date: 2010-10-04
End date: 2010-10-06
Other drugs received by patient: Aldactone; Urief; Warfarin Sodium; Alendronate Sodium; Spiriva; Magnesium Oxide; Theophylline; Ambroxol Hydrochloride; Enalapril Maleate; Seltepnon; Vasolator; Sotalol Hydrochloride
Possible Carboplatin side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from Greece on 2012-07-16
Patient: 65 year old female
Reactions: Confusional State, Pneumonia, Dyspnoea, Hypersensitivity, Wheezing, Hypotension, Pyrexia, Respiratory Failure, Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Carboplatin
Possible Carboplatin side effects in 71 year old male
Reported by a physician from Greece on 2012-07-11
Patient: 71 year old male, weighing 69.0 kg (151.8 pounds)
Reactions: Abdominal Pain, Diarrhoea, Sepsis, Tachypnoea, Febrile Neutropenia, Acute Respiratory Failure
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Xeloda
Administration route: Oral
Indication: Colorectal Cancer Metastatic
Start date: 2012-05-25
Avastin
Indication: Colorectal Cancer Metastatic
Start date: 2012-05-25
Carboplatin
Indication: Colorectal Cancer Metastatic
Start date: 2012-05-25
Other drugs received by patient: Lipidil; Indapamide; Exforge; Kerlone
Possible Carboplatin side effects in 65 year old female
Reported by a physician from Germany on 2012-06-28
Patient: 65 year old female, weighing 46.4 kg (102.1 pounds)
Reactions: Weight Decreased, Fistula, Fatigue, Nausea, Sepsis, Anaemia, General Physical Health Deterioration, Decreased Appetite, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Avastin
Indication: Ovarian Cancer
Start date: 2012-03-21
End date: 2012-04-18
Carboplatin
Dosage: auc 5,
Indication: Ovarian Cancer
Start date: 2012-02-27
End date: 2012-04-18
Paclitaxel
Dosage: last dose:15/may/2012
Indication: Ovarian Cancer
Start date: 2012-02-27
End date: 2012-04-18
Carboplatin
Dosage: auc 5, last dose:15/may/2012
End date: 2012-06-10
Paclitaxel
Dosage: last dose:15/may/2012
End date: 2012-06-10
Avastin
Dosage: last dose:15/may/2012
End date: 2012-06-10
Other drugs received by patient: Pantoprazole; Zolpidem; Novalgin
Possible Carboplatin side effects in 16 month old female
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-06-26
Patient: 16 month old female
Reactions: Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Etoposide
Dosage: 2.5 mg/kg once daily for 5 consecutive days from day 0 (ceiv regimen)
Cisplatin
Dosage: 3 mg/kg, once daily on day 0 (cecv regimen)
Indication: Brain Neoplasm Malignant
Ifosfamide
Dosage: 50 mg/kg daily for 5 consecutive days from day 0 (ceiv regimen)
Indication: Brain Neoplasm Malignant
Vincristine
Dosage: 0.05 mg/kg, 1x/day, day 0 and 7
Indication: Brain Neoplasm Malignant
Etoposide
Dosage: 2.5 mg/kg once daily on days 0, 1, and 2 (cecv regimen)
Indication: Brain Neoplasm Malignant
Carboplatin
Dosage: 10 mg/kg daily on days 0
Indication: Brain Neoplasm Malignant
Cyclophosphamide
Dosage: 50 mg/kg once daily on day 1 and 2 (cecv regimen)
Indication: Brain Neoplasm Malignant
Possible Carboplatin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-26
Patient:
Reactions: Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Bevacizumab(bevacizumab)
Dosage: 15 mg/kg (day 1 of 21 day cycle),intravenous
Indication: non-Small Cell Lung Cancer
Carboplatin
Dosage: area under the concentration time curve=5 (day 1 of 21 day cycle), intravenous
Indication: non-Small Cell Lung Cancer
Pemetrexed
Dosage: 500 mg/m2 (day 1 of 21 day cycle), intravenous
Indication: non-Small Cell Lung Cancer
Possible Carboplatin side effects in 16 month old female
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-06-25
Patient: 16 month old female
Reactions: Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Etoposide
Dosage: 2.5 mg/kg once daily on days 0, 1, and 2 (cecv regimen)
Indication: Brain Neoplasm Malignant
Cisplatin
Dosage: 3 mg/kg, once daily on day 0 (cecv regimen)
Indication: Brain Neoplasm Malignant
Etoposide
Dosage: 2.5 mg/kg once daily for 5 consecutive days from day 0 (ceiv regimen)
Carboplatin
Dosage: 10 mg/kg daily on days 0
Indication: Brain Neoplasm Malignant
Cyclophosphamide
Dosage: 50 mg/kg once daily on day 1 and 2 (cecv regimen)
Indication: Brain Neoplasm Malignant
Ifosfamide
Dosage: 50 mg/kg daily for 5 consecutive days from day 0 (ceiv regimen)
Indication: Brain Neoplasm Malignant
Vincristine
Dosage: 0.05 mg/kg, 1x/day, day 0 and 7
Indication: Brain Neoplasm Malignant
Possible Carboplatin side effects in 78 year old female
Reported by a individual with unspecified qualification from United States on 2012-06-25
Patient: 78 year old female, weighing 55.5 kg (122.1 pounds)
Reactions: Sepsis, Hypotension, Dehydration, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Docetaxel
Indication: Ovarian Epithelial Cancer
Start date: 2012-01-26
Avastin
Dosage: over 30 to 90 minutes
Indication: Ovarian Epithelial Cancer
Start date: 2012-01-26
Carboplatin
Dosage: auc 5 over 30 mins
Indication: Ovarian Epithelial Cancer
Start date: 2012-01-26
Other drugs received by patient: Dexamethasone; Lipitor; Reglan; Zofran; Atenolol; Lisinopril
Possible Carboplatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-22
Patient: female
Reactions: Wound, Streptococcal Infection, Fall, Thermal Burn, Accident, Escherichia Test Positive, Pseudomonas Test Positive, Limb Injury, Impaired Healing, Sepsis, Wound Necrosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 350 mg milligram(s), intravenous (not otherwise specified)
Indication: non-Small Cell Lung Cancer
Avastin
Dosage: 400 mg millgram(s), intravenous (not otherwise specified)
Indication: non-Small Cell Lung Cancer
Start date: 2012-03-07
End date: 2012-03-07
Vinorelbine
Dosage: 80 mg milligram(s), oral
Indication: non-Small Cell Lung Cancer
Other drugs received by patient: Emperal; Prednisolon Nausea (Nausea) / 00016201 /
Possible Carboplatin side effects in female
Reported by a physician from Denmark on 2012-06-22
Patient: female
Reactions: Impaired Healing, Wound, Sepsis, Thermal Burn, Streptococcal Infection, Fall, Wound Necrosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vinorelbine Tartrate
Dosage: 80 mg, unk
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2012-03-07
Carboplatin
Dosage: 350 mg, unk
Indication: non-Small Cell Lung Cancer
Start date: 2012-03-07
Avastin
Dosage: 400 mg, unk
Indication: non-Small Cell Lung Cancer
Start date: 2012-03-07
End date: 2012-03-07
Other drugs received by patient: Prednisolone; Emperal
Possible Carboplatin side effects in
Reported by a consumer/non-health professional from Germany on 2012-06-21
Patient:
Reactions: Sepsis, Progressive Multifocal Leukoencephalopathy, Meningitis Tuberculous
Adverse event resulted in: death
Drug(s) suspected as cause:
Cisplatin
Dosage: unk
Indication: Product Used FOR Unknown Indication
Neupogen
Dosage: unk
Indication: Product Used FOR Unknown Indication
Rituxan
Dosage: unk
Indication: Product Used FOR Unknown Indication
Cyclophosphamide
Dosage: 2000 mg/m2, unk
Indication: Product Used FOR Unknown Indication
Carboplatin
Dosage: unk
Indication: Product Used FOR Unknown Indication
Etoposide
Dosage: unk
Indication: Product Used FOR Unknown Indication
Zevalin
Dosage: unk
Indication: Product Used FOR Unknown Indication
Prednisone TAB
Dosage: unk
Indication: Product Used FOR Unknown Indication
Busulfan
Dosage: 12 mg/kg, unk
Indication: Product Used FOR Unknown Indication
Fludara
Dosage: 250 mg/m2, unk
Indication: Product Used FOR Unknown Indication
Doxorubicin Hydrochloride
Dosage: unk
Indication: Product Used FOR Unknown Indication
Ifosfamide
Dosage: unk
Indication: Product Used FOR Unknown Indication
Vincristine Sulfate
Dosage: unk
Indication: Product Used FOR Unknown Indication
Possible Carboplatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-19
Patient: female
Reactions: Wound, Pseudomonas Infection, Thermal Burn, Fall, Streptococcal Infection, Impaired Healing, Sepsis, Escherichia Infection, Wound Necrosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 350 mg
Indication: non-Small Cell Lung Cancer
Vinorelbine
Dosage: 80 mg
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Avastin
Dosage: 400 mg
Indication: non-Small Cell Lung Cancer
Start date: 2012-03-07
End date: 2012-03-07
Other drugs received by patient: Emperal; Prednisolone
Possible Carboplatin side effects in female
Reported by a physician from United States on 2012-06-19
Patient: female, weighing 86.0 kg (189.2 pounds)
Reactions: Vomiting, Escherichia Test Positive, Fatigue, Nausea, Urinary Tract Infection, Sepsis, Enterococcus Test Positive, Culture Urine Positive
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Taxol
Dosage: 324 mg
Carboplatin
Dosage: 536 mg
Possible Carboplatin side effects in male
Reported by a physician from United States on 2012-06-13
Patient: male, weighing 85.3 kg (187.7 pounds)
Reactions: Respiratory Failure, Sepsis, Thrombocytopenia, Renal Failure Acute, Leukopenia, Infectious Peritonitis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 6 df, q21d
Indication: non-Small Cell Lung Cancer
Start date: 2009-09-04
End date: 2009-09-04
Pemetrexed Disodium
Dosage: 500 mg/m2, q21d
Indication: non-Small Cell Lung Cancer
Start date: 2009-09-04
End date: 2009-09-04
Avastin
Dosage: 15 mg/m2, q21d
Indication: non-Small Cell Lung Cancer
Start date: 2009-09-04
End date: 2009-09-04
Other drugs received by patient: Folic Acid; Duragesic-100; Vitamin B-12; Megestrol Acetate; Dexamethasone; Nexium; Fluconazole; Norco
Possible Carboplatin side effects in
Reported by a consumer/non-health professional from Canada on 2012-06-13
Patient:
Reactions: Sepsis, Progressive Multifocal Leukoencephalopathy, Meningitis Tuberculous
Adverse event resulted in: death
Drug(s) suspected as cause:
Neupogen
Dosage: unk
Indication: Product Used FOR Unknown Indication
Rituxan
Dosage: unk
Indication: Product Used FOR Unknown Indication
Busulfan
Dosage: 12 mg/kg, qd
Indication: Product Used FOR Unknown Indication
Cisplatin
Dosage: unk
Indication: Product Used FOR Unknown Indication
Cyclophosphamide
Dosage: 2000 mg/m2, qd
Indication: Product Used FOR Unknown Indication
Etoposide
Dosage: unk
Indication: Product Used FOR Unknown Indication
Ifosfamide
Dosage: unk
Indication: Product Used FOR Unknown Indication
Zevalin
Dosage: unk
Indication: Product Used FOR Unknown Indication
Prednisone TAB
Dosage: unk
Indication: Product Used FOR Unknown Indication
Vincristine Sulfate
Dosage: unk
Indication: Product Used FOR Unknown Indication
Fludara
Dosage: 250 mg/m2, qd
Indication: Product Used FOR Unknown Indication
Doxorubicin Hydrochloride
Dosage: unk
Indication: Product Used FOR Unknown Indication
Carboplatin
Dosage: unk
Indication: Product Used FOR Unknown Indication
Possible Carboplatin side effects in female
Reported by a physician from United States on 2012-06-07
Patient: female, weighing 150.6 kg (331.2 pounds)
Reactions: Diarrhoea, Sepsis, Neutropenia, Thrombocytopenia, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Bevacizumab
Dosage: 10 mg/kg, qd
Indication: Metastatic Malignant Melanoma
Start date: 2012-05-18
End date: 2012-05-18
Afinitor
Dosage: 5 mg, qw3 (m, w, f) all 4 weeks, repeat q28 days
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2012-05-21
End date: 2012-05-25
Taxol
Dosage: 80 mg/m2, unk
Indication: Metastatic Malignant Melanoma
Start date: 2012-05-18
End date: 2012-05-18
Carboplatin
Possible Carboplatin side effects in female
Reported by a physician from United States on 2012-06-07
Patient: female, weighing 150.6 kg (331.2 pounds)
Reactions: Diarrhoea, Sepsis, Neutropenia, Thrombocytopenia, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Taxol
Dosage: 80 mg/m2, unk
Indication: Metastatic Malignant Melanoma
Start date: 2012-05-18
End date: 2012-05-18
Afinitor
Dosage: 5 mg, qw3 (m, w, f) all 4 weeks, repeat q28 days
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2012-05-21
End date: 2012-05-25
Bevacizumab
Dosage: 10 mg/kg, qd
Indication: Metastatic Malignant Melanoma
Start date: 2012-05-18
End date: 2012-05-18
Possible Carboplatin side effects in 65 year old female
Reported by a physician from Greece on 2012-06-06
Patient: 65 year old female
Reactions: Confusional State, Hypersensitivity, Hypotension, Toxicity To Various Agents, Respiratory Failure, Heart Rate Increased, Sepsis, Acute Respiratory Distress Syndrome, Infusion Related Reaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Possible Carboplatin side effects in 65 year old female
Reported by a physician from United States on 2012-06-06
Patient: 65 year old female, weighing 150.6 kg (331.2 pounds)
Reactions: Diarrhoea, Sepsis, Platelet Count Decreased, Neutrophil Count Decreased, Renal Failure Acute
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Everolimus
Indication: Metastatic Malignant Melanoma
Start date: 2012-05-18
Carboplatin
Dosage: 5 auc
Indication: Metastatic Malignant Melanoma
Start date: 2012-05-18
Paclitaxel
Dosage: last dose taken on 18/may/2012
Indication: Metastatic Malignant Melanoma
Start date: 2012-05-18
Avastin
Dosage: last dose taken 18/may/2012
Indication: Metastatic Malignant Melanoma
Start date: 2012-05-18
Possible Carboplatin side effects in
Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-06-02
Patient:
Reactions: Sepsis
Drug(s) suspected as cause:
Cetuximab
Fluorouracil
Cetuximab
Cisplatin
Carboplatin
Possible Carboplatin side effects in
Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-06-02
Patient:
Reactions: Sepsis
Drug(s) suspected as cause:
Cisplatin
Carboplatin
Dosage: dose unit:5
Fluorouracil
Possible Carboplatin side effects in
Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-06-02
Patient:
Reactions: Sepsis
Drug(s) suspected as cause:
Cisplatin
Carboplatin
Dosage: dose unit:5
Fluorouracil
Possible Carboplatin side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-01
Patient: 53 year old male, weighing 42.0 kg (92.4 pounds)
Reactions: White Blood Cell Count Decreased, Fall, Hypokalaemia, Tracheal Obstruction, Sepsis, Platelet Count Decreased, Hypoalbuminaemia, Neutrophil Count Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cetuximab
Indication: Head and Neck Cancer
Start date: 2012-03-07
End date: 2012-03-07
Fluorouracil
Dosage: last dose: 20apr12
Indication: Head and Neck Cancer
Start date: 2012-03-19
End date: 2012-04-20
Carboplatin
Dosage: 1df= 5auc last dose: 16apr12
Indication: Head and Neck Cancer
Start date: 2012-03-19
End date: 2012-04-16
Other drugs received by patient: Oxycontin; Oxycodone Hydrochloride
Possible Carboplatin side effects in 57 year old female
Reported by a individual with unspecified qualification from United States on 2012-05-31
Patient: 57 year old female, weighing 51.5 kg (113.3 pounds)
Reactions: Hyperglycaemia, Sepsis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: iv over 90 min on day 1last dose prior to sae: 31/oct/2011).
Indication: Oesophageal Adenocarcinoma
Start date: 2011-10-03
Herceptin
Dosage: iv over 30-60 min on days 8, 15, 22, 29 and 36
Herceptin
Dosage: iv over 30-90 min on day 57
Paclitaxel
Dosage: iv over 1 hr on days 1, 8, 15, 22, 29 and 36last dose prior to sae: 31/oct/2011).
Indication: Oesophageal Adenocarcinoma
Start date: 2011-10-03
Dexamethasone
Indication: Product Used FOR Unknown Indication
Herceptin
Dosage: iv over 30-90 min on day 1, maintenance therapy cycle 21
Carboplatin
Dosage: iv over 1 hr on days 1, 8, 15, 22, 29 and 36last dose prior to sae: 31/oct/2011).
Indication: Oesophageal Adenocarcinoma
Possible Carboplatin side effects in female
Reported by a individual with unspecified qualification from United States on 2012-05-31
Patient: female, weighing 57.6 kg (126.7 pounds)
Reactions: Diarrhoea, Disseminated Intravascular Coagulation, Sepsis, Febrile Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Docetaxel
Dosage: temporarily interrupted
Indication: Breast Cancer
Start date: 2012-04-13
End date: 2012-05-04
Herceptin
Dosage: loading dose, temporarily interrupted
Indication: Breast Cancer
Start date: 2012-04-13
End date: 2012-05-04
Carboplatin
Indication: Breast Cancer
Start date: 2012-04-13
Pertuzumab
Dosage: loading dose
Indication: Breast Cancer
Start date: 2012-04-13
Other drugs received by patient: Zofran; Lovaza; Tylenol; Clindamycin
Possible Carboplatin side effects in male
Reported by a physician from United States on 2012-05-30
Patient: male, weighing 41.7 kg (91.7 pounds)
Reactions: White Blood Cell Count Decreased, Fall, Hypokalaemia, Tracheal Obstruction, Sepsis, Platelet Count Decreased, Hypoalbuminaemia, Neutrophil Count Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: auc 5, on day one
Indication: Head and Neck Cancer
Start date: 2012-03-19
End date: 2012-04-16
Blinded Therapy
Dosage: 400 mg/m2, on day one of cycle one only
Indication: Head and Neck Cancer
Start date: 2012-03-07
End date: 2012-03-07
Fluorouracil
Dosage: 1000 mg/m2 on days one to four
Indication: Head and Neck Cancer
Start date: 2012-03-19
End date: 2012-04-20
Other drugs received by patient: Oxycodone; Oxycontin
Page 1 Next >>
|
